Layoffs across health agencies have eliminated workers who handled Freedom of Information Act requests at the CDC, FDA, and ...

In the US, the incidence of pancreatic cancer is increasing in patients of all ages, and the incidence of colorectal cancer is increasing in patients aged 15-34 years.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

(HealthDay News) — The US Food and Drug Administration (FDA) announced that it is shifting away from requiring animal testing for the development of monoclonal antibodies and other drugs and will ...

Adherence to ACS nutrition and activity guidelines is associated with a lower risk of death among nonsmoking survivors of obesity-related cancers, researchers found.

The most common projected cancers in adults were lung cancer, colon cancer, leukemia, bladder cancer, and stomach cancer.

Patients covered by Medicaid are just as likely as those with private insurance to be charged a copay for sending a message to their physician or other provider through a patient portal, a survey ...

The Honoring Our Fallen Heroes Act is considered crucial by its supporters, with climate change fueling an increase in wildfire frequency and firefighting deemed carcinogenic by the World Health ...

Five-year data from the KEYNOTE-048 trial support the use of pembrolizumab and pembrolizumab-chemotherapy as standards of care, researchers wrote.

The Trump administration is attempting to slash NIH funding, terminate research grants, and reduce the agency’s workforce.

Future prospective studies and clinical trials are necessary to determine whether vitamin D supplementation can improve survival outcomes in pancreatic cancer patients,” the researchers wrote.

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) as first-line treatment for adults with unresectable or metastatic HCC.